SRC and cancer: It has been shown that matrine can interact with the Src kinase structural domain to inhibit Src activity and downregulate MAPK/ERK, JAK2/STAT3, and PI3K/AKT phosphorylation signaling pathways, thereby inhibiting the proliferation of cancer cells [23].